Sfoglia per Autore
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis.
2018 Alivernini, Stefano; Pugliese, D; Tolusso, Barbara; Bui, L; Petricca, Luca; Guidi, Luisa; Mirone, Luisa; Rapaccini, Gian Ludovico; L, ; Federico, F; Ferraccioli, Gianfranco; Armuzzi, Alessandro; Gremese, Elisa
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver
2018 Lopetuso, Loris Riccardo; Mocci, Giammarco; Marzo, Manuela; D’Aversa, Francesca; Rapaccini, Gian Lodovico; Guidi, Luisa; Armuzzi, Alessandro; Gasbarrini, Antonio; Papa, Alfredo
Sustained clinical efficacy and mucosal healing of thiopurine maintenance treatment in ulcerative colitis: A real-life study
2018 Pugliese, D.; Aratari, A.; Festa, S.; Ferraro, P. M.; Monterubbianesi, R.; Guidi, L.; Scribano, M. L.; Papi, C.; Armuzzi, A.
Watery stools and metabolic acidosis
2017 Ferrari, Maria Chiara; Miele, Luca; Guidi, Luisa; Rindi, Guido; Rocchi, Carlo; Castaldi, Paola; Alfieri, Sergio; Gasbarrini, Antonio; Grieco, Antonio; Rapaccini, Gianlodovico
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
2017 Fiorino, G; Manetti, N; Armuzzi, Alessandro; Orlando, A; Variola, A; Bonovas, S; Bossa, F; Maconi, G; Dʼincà, R; Lionetti, P; Cantoro, L; Fries, W; Annunziata, Ml; Costa, F; Terpin, Mm; Biancone, L; Cortelezzi, Cc; Amato, A; Ardizzone, S; Danese, S; Guidi, Luisa; Rizzuto, G; Massella, A; Andriulli, A; Massari, A; Lorenzon, G; Ghione, S; Kohn, A; Ventra, A; Annese, V
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?
2016 Andrisani, Gianluca; Armuzzi, Alessandro; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Papa, Alfredo; Guidi, Luisa
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis
2016 Pugliese, Daniela; Felice, Carla; Landi, Rosario; Papa, Alfredo; Guidi, Luisa; Armuzzi, Alessandro
Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.
2016 Biancone, L; Armuzzi, Alessandro; Scribano, Ml; D'Inca, R; Castiglione, F; Papi, C; Angelucci, E; Daperno, M; Mocciaro, F; Riegler, G; Fries, W; Meucci, G; Alvisi, P; Spina, L; Ardizzone, S; Petruzziello, C; Ruffa, A; Kohn, A; Vecchi, M; Guidi, Luisa; Di Mitri, R; Renna, S; Emma, C; Rogai, F; Rossi, A; Orlando, A; Pallone, F.
Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future
2016 Pugliese, Daniela; Felice, Carla; Papa, Alfredo; Gasbarrini, Antonio; Rapaccini, Gian Lodovico; Guidi, Luisa; Armuzzi, Alessandro
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
2015 Pugliese, Daniela; Guidi, Luisa; Ferraro, Pietro Manuel; Marzo, Manuela; Felice, Carla; Celleno, Leonardo; Landi, Rosario; Andrisani, Gianluca; Pizzolante, Fabrizio; De Vitis, Italo; Papa, Alfredo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro
Management of perianal fistulas in Crohn's disease: an up-to-date review
2015 Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Andrisani, Gianluca; Mocci, Giammarco; Armuzzi, Alessandro; Guidi, Luisa
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases
2015 Felice, Carla; Marzo, Manuela; Pugliese, Daniela; Papa, Alfredo; Rapaccini, Gian Ludovico; Guidi, Luisa; Armuzzi, Alessandro
Linking estrogen receptor β expression with inflammatory bowel disease activity
2015 Pierdominici, M.; Maselli, A.; Varano, B.; Barbati, C.; Cesaro, P.; Spada, C.; Zullo, A.; Lorenzetti, R.; Rosati, M.; Rainaldi, G.; Limiti, M. R.; Guidi, L.; Conti, L.; Gessani, S.
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
2014 Armuzzi, Alessandro; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
2014 Armuzzi, Alessandro; Gasbarrini, Antonio; Guidi, Luisa
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis.
2014 Papa, Alfredo; Felice, Carla; Marzo, Manuela; De Vitis, Italo; Guidi, Luisa.
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
2014 Guidi, Luisa; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents
2013 Guidi, Luisa; Felice, Carla; Procoli, Annabella; Bonanno, Giuseppina; Martinelli, Enrica; Marzo, Manuela; Mocci, Giammarco; Pugliese, Daniela; Andrisani, Gianluca; Danese, Silvio; De Vitis, Italo; Papa, Alfredo; Armuzzi, Alessandro; Rutella, Sergio
Mucosal healing in ulcerative colitis: surveillance or colectomy?
2013 Andrisani, Gianluca; Papa, Alfredo; Guidi, Luisa; Armuzzi, Alessandro
Adalimumab in active ulcerative colitis: a "real-life" observational study
2013 Armuzzi, Alessandro; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Incà, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, Luisa; Papi, C.
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2018 | Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. | Alivernini, Stefano; Pugliese, D; Tolusso, Barbara; Bui, L; Petricca, Luca; Guidi, Luisa; Mirone, Luisa; Rapaccini, Gian Ludovico; L, ; Federico, F; Ferraccioli, Gianfranco; Armuzzi, Alessandro; Gremese, Elisa | |
| 1-gen-2018 | Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver | Lopetuso, Loris Riccardo; Mocci, Giammarco; Marzo, Manuela; D’Aversa, Francesca; Rapaccini, Gian Lodovico; Guidi, Luisa; Armuzzi, Alessandro; Gasbarrini, Antonio; Papa, Alfredo | |
| 1-gen-2018 | Sustained clinical efficacy and mucosal healing of thiopurine maintenance treatment in ulcerative colitis: A real-life study | Pugliese, D.; Aratari, A.; Festa, S.; Ferraro, P. M.; Monterubbianesi, R.; Guidi, L.; Scribano, M. L.; Papi, C.; Armuzzi, A. | |
| 1-gen-2017 | Watery stools and metabolic acidosis | Ferrari, Maria Chiara; Miele, Luca; Guidi, Luisa; Rindi, Guido; Rocchi, Carlo; Castaldi, Paola; Alfieri, Sergio; Gasbarrini, Antonio; Grieco, Antonio; Rapaccini, Gianlodovico | |
| 1-gen-2017 | The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. | Fiorino, G; Manetti, N; Armuzzi, Alessandro; Orlando, A; Variola, A; Bonovas, S; Bossa, F; Maconi, G; Dʼincà, R; Lionetti, P; Cantoro, L; Fries, W; Annunziata, Ml; Costa, F; Terpin, Mm; Biancone, L; Cortelezzi, Cc; Amato, A; Ardizzone, S; Danese, S; Guidi, Luisa; Rizzuto, G; Massella, A; Andriulli, A; Massari, A; Lorenzon, G; Ghione, S; Kohn, A; Ventra, A; Annese, V | |
| 1-gen-2016 | What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? | Andrisani, Gianluca; Armuzzi, Alessandro; Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Papa, Alfredo; Guidi, Luisa | |
| 1-gen-2016 | Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis | Pugliese, Daniela; Felice, Carla; Landi, Rosario; Papa, Alfredo; Guidi, Luisa; Armuzzi, Alessandro | |
| 1-gen-2016 | Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study. | Biancone, L; Armuzzi, Alessandro; Scribano, Ml; D'Inca, R; Castiglione, F; Papi, C; Angelucci, E; Daperno, M; Mocciaro, F; Riegler, G; Fries, W; Meucci, G; Alvisi, P; Spina, L; Ardizzone, S; Petruzziello, C; Ruffa, A; Kohn, A; Vecchi, M; Guidi, Luisa; Di Mitri, R; Renna, S; Emma, C; Rogai, F; Rossi, A; Orlando, A; Pallone, F. | |
| 1-gen-2016 | Anti TNF-α therapy for ulcerative colitis: current status and prospects for the future | Pugliese, Daniela; Felice, Carla; Papa, Alfredo; Gasbarrini, Antonio; Rapaccini, Gian Lodovico; Guidi, Luisa; Armuzzi, Alessandro | |
| 1-gen-2015 | Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study | Pugliese, Daniela; Guidi, Luisa; Ferraro, Pietro Manuel; Marzo, Manuela; Felice, Carla; Celleno, Leonardo; Landi, Rosario; Andrisani, Gianluca; Pizzolante, Fabrizio; De Vitis, Italo; Papa, Alfredo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro | |
| 1-gen-2015 | Management of perianal fistulas in Crohn's disease: an up-to-date review | Marzo, Manuela; Felice, Carla; Pugliese, Daniela; Andrisani, Gianluca; Mocci, Giammarco; Armuzzi, Alessandro; Guidi, Luisa | |
| 1-gen-2015 | Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases | Felice, Carla; Marzo, Manuela; Pugliese, Daniela; Papa, Alfredo; Rapaccini, Gian Ludovico; Guidi, Luisa; Armuzzi, Alessandro | |
| 1-gen-2015 | Linking estrogen receptor β expression with inflammatory bowel disease activity | Pierdominici, M.; Maselli, A.; Varano, B.; Barbati, C.; Cesaro, P.; Spada, C.; Zullo, A.; Lorenzetti, R.; Rosati, M.; Rainaldi, G.; Limiti, M. R.; Guidi, L.; Conti, L.; Gessani, S. | |
| 1-gen-2014 | Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. | Armuzzi, Alessandro; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Guidi, Luisa | |
| 1-gen-2014 | Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy | Armuzzi, Alessandro; Gasbarrini, Antonio; Guidi, Luisa | |
| 1-gen-2014 | Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. | Papa, Alfredo; Felice, Carla; Marzo, Manuela; De Vitis, Italo; Guidi, Luisa. | |
| 1-gen-2014 | Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. | Guidi, Luisa; Papa, Alfredo; De Vitis, Italo; Rapaccini, Gian Ludovico; Armuzzi, Alessandro | |
| 1-gen-2013 | FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents | Guidi, Luisa; Felice, Carla; Procoli, Annabella; Bonanno, Giuseppina; Martinelli, Enrica; Marzo, Manuela; Mocci, Giammarco; Pugliese, Daniela; Andrisani, Gianluca; Danese, Silvio; De Vitis, Italo; Papa, Alfredo; Armuzzi, Alessandro; Rutella, Sergio | |
| 1-gen-2013 | Mucosal healing in ulcerative colitis: surveillance or colectomy? | Andrisani, Gianluca; Papa, Alfredo; Guidi, Luisa; Armuzzi, Alessandro | |
| 1-gen-2013 | Adalimumab in active ulcerative colitis: a "real-life" observational study | Armuzzi, Alessandro; Biancone, L; Daperno, M; Coli, A; Pugliese, D; Annese, V; Aratari, A; Ardizzone, S; Balestrieri, P; Bossa, F; Cappello, M; Castiglione, F; Cicala, M; Danese, S; D'Incà, R; Dulbecco, P; Feliciangeli, G; Fries, W; Genise, S; Gionchetti, P; Gozzi, S; Kohn, A; Lorenzetti, R; Milla, M; Onali, S; Orlando, A; Papparella, Lg; Renna, S; Ricci, C; Rizzello, F; Sostegni, R; Guidi, Luisa; Papi, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile